# Pilot Study of AVT16 in Healthy Adult Subjects

> **NCT06400719** · PHASE1 · COMPLETED · sponsor: **Alvotech Swiss AG** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** AVT16

## Key facts

- **NCT ID:** NCT06400719
- **Lead sponsor:** Alvotech Swiss AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-29
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400719, "Pilot Study of AVT16 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06400719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*